BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 15607568)

  • 21. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
    Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
    Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
    Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
    Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
    Weng MS; Ho CT; Ho YS; Lin JK
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1.
    Giordano A; Calvani M; Petillo O; Grippo P; Tuccillo F; Melone MA; Bonelli P; Calarco A; Peluso G
    Cell Death Differ; 2005 Jun; 12(6):603-13. PubMed ID: 15846373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines.
    Slade RF; Hunt DA; Pochet MM; Venema VJ; Hennigar RA
    Anticancer Res; 2003; 23(2B):1235-43. PubMed ID: 12820377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid metabolism as a target for obesity treatment.
    Ronnett GV; Kim EK; Landree LE; Tu Y
    Physiol Behav; 2005 May; 85(1):25-35. PubMed ID: 15878185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty acid synthase: a metabolic oncogene in prostate cancer?
    Baron A; Migita T; Tang D; Loda M
    J Cell Biochem; 2004 Jan; 91(1):47-53. PubMed ID: 14689581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines.
    Pizer ES; Chrest FJ; DiGiuseppe JA; Han WF
    Cancer Res; 1998 Oct; 58(20):4611-5. PubMed ID: 9788612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C75 [4-methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid] activates carnitine palmitoyltransferase-1 in isolated mitochondria and intact cells without displacement of bound malonyl CoA.
    Yang N; Kays JS; Skillman TR; Burris L; Seng TW; Hammond C
    J Pharmacol Exp Ther; 2005 Jan; 312(1):127-33. PubMed ID: 15356215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
    Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF
    Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.
    Zeng L; Biernacka KM; Holly JM; Jarrett C; Morrison AA; Morgan A; Winters ZE; Foulstone EJ; Shield JP; Perks CM
    Endocr Relat Cancer; 2010 Jun; 17(2):539-51. PubMed ID: 20356977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of genes regulating malonyl-CoA in human skeletal muscle.
    Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
    J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the inactivation of rat fatty acid synthase by C75: inhibition of partial reactions and protection by substrates.
    Rendina AR; Cheng D
    Biochem J; 2005 Jun; 388(Pt 3):895-903. PubMed ID: 15715522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
    Menendez JA; Vellon L; Lupu R
    Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of the phosphoenolpyruvate carboxykinase gene in human colon tumors and induction by omega-3 fatty acids.
    Blouin JM; Bortoli S; Nacfer M; Collinet M; Penot G; Laurent-Puig P; Forest C
    Biochimie; 2010 Dec; 92(12):1772-7. PubMed ID: 20691246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals.
    Puig T; Relat J; Marrero PF; Haro D; Brunet J; Colomer R
    Anticancer Res; 2008; 28(6A):3671-6. PubMed ID: 19189648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.
    Furuta E; Pai SK; Zhan R; Bandyopadhyay S; Watabe M; Mo YY; Hirota S; Hosobe S; Tsukada T; Miura K; Kamada S; Saito K; Iiizumi M; Liu W; Ericsson J; Watabe K
    Cancer Res; 2008 Feb; 68(4):1003-11. PubMed ID: 18281474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
    Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
    Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.